Identification of a Trp64-nonsense mutation in the LpL gene explains marked reduction in LpL mass in affected subjects, contributing to the understanding of the genetic basis of Type I hyperlipoproteinemia.
No takes yet. Share an insight, caveat, or question.
May link Trp64 nonsense mutation to LpL deficiency; hypothesis-generating for Type I hyperlipoproteinemia genetics and needs replication.
Sprecher et al. (1992) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: